Opioid Crisis Hits Home: Uncle’s Overdose Spurs Medicaid Official To Change Course
Andrey Ostrovsky, who until last month was chief medical officer for Medicaid, quit his job so he could more directly fight the stigma of drug addiction.
The independent source for health policy research, polling, and news.
1,261 - 1,280 of 1,591 Results
Andrey Ostrovsky, who until last month was chief medical officer for Medicaid, quit his job so he could more directly fight the stigma of drug addiction.
Medicare is discouraging regional offices from levying fines for “one-time mistakes” or from using daily fines that seek to put pressure on nursing homes to make changes.
This is a tactic that we’ve seen before.
One Indiana addiction specialist doesn't shy away from telemedicine, but he still requires in-person visits to begin and maintain his patients' Suboxone prescriptions.
Officials in marijuana-friendly states reacted strongly to new guidance from U.S. Attorney General Jeff Sessions giving federal prosecutors leeway to crack down on cannabis.
Data and safety monitoring boards work under a cloak of secrecy meant to prevent undue influence by stakeholders, such as companies or the government. In the Trump era, some worry the anonymity could actually invite it.
The statistic is accurate but experts say other factors make it difficult to say indicators to think about that make it hard to say it's a "huge win."
Nonetheless, federal officials report sign-ups are robust so far this year.
President Joe Biden signed a pair of health-related executive orders this week that would, among other things, reopen enrollment under the Affordable Care Act and start to reverse former President Donald Trump’s anti-abortion policies. Meanwhile, Congress remains bogged down with taking up the next round of covid-19 relief. Joanne Kenen of Politico, Mary Ellen McIntire of CQ Roll Call and Shefali Luthra of The 19th join KHN’s Julie Rovner to discuss these issues and more. Plus, for “extra credit,” the panelists recommend their favorite health policy stories of the week they think you should read, too.
Last year, the pharma industry’ biggest trade group raised millions to change the conversation about drug pricing.
It’s a regular part of the politically charged debate over health care. But the lines sometimes blur between rhetoric and how Canada’s system actually works.
While insulin is the poster child for outrageous prescription costs, patients are paying ever more to treat depression, asthma, HIV, cholesterol and more. And the pandemic has overtaken efforts to force the issue in Congress.
Even if the Republican from Maine can get her party to go along, her suggestions to bolster the individual insurance market may be too little, too late.
Interviews with immigrants from 15 countries and pediatricians in eight states reveal that fear of deportation is putting parents and children under heightened stress, impeding daily activities and jeopardizing long-term health.
The federal agents warned store owners that importing drugs from foreign countries is illegal and that those helping “administer” such medicines could face penalties.
In this Facebook Live, KHN’s Julie Appleby answers questions about President Donald Trump’s executive order regarding insurance.
In this Facebook Live chat, KHN's Jay Hancock answers questions about President Donald Trump’s announcement that he will end federal payments for the Affordable Care Act’s cost-sharing reductions.
This controversial center created by the Affordable Care Act has a Canadian fan base even as it is at risk in the U.S.
Ineligible for subsidies, a Tennessee woman quit her job to get an affordable health care premium. Conventional steps — such as maxing out your 401(k) contribution each year — may also do the job, financial planners say.
Controversial research methods by university researcher unlikely to prompt federal response or institutional change, experts say.
© 2026 KFF